GLP-1 Drugs Show Promise, But Researchers Question Lifelong Use, Prescriptions for Children, and Cost Barriers

GLP-1 use rising rapidly among U.S. adolescents, young adults

Adolescents and young adults in the U.S. are increasingly using popular GLP-1 weight-loss drugs alone or in conjunction with metabolic and bariatric surgery (MBS) to manage obesity.

How the Future of GLP-1 Affordability Depends on Competition

By Amanda Frost, PhD Vice President, Research, PCMA  There is no shortage of opinions these days about GLP-1 prescription drugs: touting benefits for patients; concerns about sky-rocketing drug costs for employers and governments; praise for manufacturers lowering the list prices; and, of course, one brand drug company suing another over their “misleading” television advertisements. And all of these can be true at the same time. The GLP-1 market…

GLP-1 Drugs Show Promise, But Researchers Question Lifelong Use, Prescriptions for Children, and Cost Barriers

More than 29 million Americans use GLP-1s, but researchers are expressing concerns about long-term use, especially in children, and cost barriers.